4//SEC Filing
Engle James R 4
Accession 0001225208-11-011291
CIK 0001405197other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 5:53 PM ET
Size
6.3 KB
Accession
0001225208-11-011291
Insider Transaction Report
Form 4
Engle James R
Sr. VP, Information Technology
Transactions
- Tax Payment
Common Stock
2011-04-01$26.94/sh−912$24,569→ 3,655 total - Award
Common Stock
2011-04-01+1,936→ 4,567 total
Footnotes (2)
- [F1]The transaction reported in this row involves the settlement of performance share units into common stock that were granted pursuant to our 2009 Long-Term Incentive Plan.
- [F2]Includes restricted share units representing the right to receive 1,754 shares of the Issuer's common stock that will vest in equal annual installments on April 1, 2012 and April 1, 2013, as detailed in a restricted share unit award agreement by and between the Issuer and the Reporting Person, dated as of September 30, 2009.
Documents
Issuer
Talecris Biotherapeutics Holdings Corp.
CIK 0001405197
Entity typeother
Related Parties
1- filerCIK 0001472090
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 5:53 PM ET
- Size
- 6.3 KB